CFO
ALKS icon

CVA Family Office’s Alkermes ALKS Stock Holding History

CVA Family Office’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Buy
+32
New +$993 ﹤0.01% 1631

Other funds holding ALKS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

CVA Family Office's ALKS Position: Q1 2026 in Review

CVA Family Office opened a new position in Alkermes (ALKS) in Q1 2026: 32 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #1631 among its holdings.

388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • CVA Family Office held 32 shares of Alkermes worth $1.13K as of Q1 2026.
  • Alkermes was a new CVA Family Office position in Q1 2026.
  • Alkermes made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1631 holding.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.